The Mitogenic Effect of Lipopolysaccharide on Bone Marrow-derived Mouse Lymphocytes. Lipid A As the Mitogenic Part of the Molecule
Overview
General Medicine
Authors
Affiliations
Lipopolysaccharides with different structure, isolated from different mutant strains of Escherichia coli and Salmonella bacteria, and chemical degradation products of these lipopolysaccharides have been employed to investigate which part of the lipopolysaccharide molecule exerts mitogenic effects on bone marrow-derived mouse lymphocytes. Within the structure of lipopolysaccharide consisting of lipid A, a core polysaccharide, and the O-polysaccharide antigen, lipid A was found to be the mitogenic part. The mitogenic effect of lipid A, consisting of phosphorylated glucosamine disaccharide units with ester- and amide-linked fatty acids, was lost after alkali treatment, which removes ester-linked fatty acids. Insertion of the lipid A portion of lipopolysaccharides into the lipid bilayer of the plasma membranes of bone marrow-derived lymphocytes is discussed as the initial mitogenic action.
Le Coz C, Bengsch B, Khanna C, Trofa M, Ohtani T, Nolan B J Allergy Clin Immunol. 2019; 144(6):1660-1673.
PMID: 31445098 PMC: 6900457. DOI: 10.1016/j.jaci.2019.08.007.
Human TNF-Luc reporter mouse: A new model to quantify inflammatory responses.
Minshawi F, White M, Muller W, Humphreys N, Jackson D, Campbell B Sci Rep. 2019; 9(1):193.
PMID: 30655563 PMC: 6336827. DOI: 10.1038/s41598-018-36969-x.
Effect of bacterial lipopolysaccharides on morphogenetic activity in wheat somatic calluses.
Evseeva N, Tkachenko O, Burygin G, Matora L, Lobachev Y, Shchyogolev S World J Microbiol Biotechnol. 2017; 34(1):3.
PMID: 29204736 DOI: 10.1007/s11274-017-2386-3.
Toll-like receptors and B cells: functions and mechanisms.
Buchta C, Bishop G Immunol Res. 2014; 59(1-3):12-22.
PMID: 24847763 DOI: 10.1007/s12026-014-8523-2.
Understanding how lipopolysaccharide impacts CD4 T-cell immunity.
McAleer J, Vella A Crit Rev Immunol. 2009; 28(4):281-99.
PMID: 19166381 PMC: 3549535. DOI: 10.1615/critrevimmunol.v28.i4.20.